Actualización Integral en TAR – Webinar 2025

Josep M Llibre, MD, PhD, received his MD in the Universitat de Barcelona, and obtained his specialty in Internal Medicine and his PhD in the Universitat Autònoma de Barcelona. He is a member of the panel of Antiretroviral treatment guidelines at the GeSIDA group (AIDS group of the SEIMC Spanish society), and an expert advisor of the Catalan Health Institute (ICS) on antiretroviral treatment and hepatitis C (PADEICS). He started caring for patients with HIV/AIDS at the beginning of the epidemic in Spain in 1987. His main areas of interest in HIV Medicine include the clinical implications of HIV-1 resistance, the analysis of safety and efficacy in HIV-1 antiretroviral treatment clinical trials (both in naïve and pre-treated patients), with a special interest in drug efficacy and pharmacoeconomics, and hepatitis C co-infection. He has published widely in journals and book chapters, as well as HIV/AIDS medical webs, on clinical aspects of HIV-1 treatment and care, HIV-1 resistance, clinical reviews, positioning papers, treatment intensification and simplification strategies, and participated in many pivotal clinical trials. He has also published in basic science research journals. He collaborates as an editor and/or peer-reviewing with many top international medical journals. He is involved in HIV Medical Educational training in Spain and other European, as well as Asian Countries.

Pedro Cahn has been Scientific Director of Fundación Huésped since 1989 and former President of the International AIDS Society (IAS) for the period 2006-2008. Former Head and current Consultant of the Infectology Division of the Juan A. Fernández Hospital in Buenos Aires, Argentina. He is also Full Professor of the Department of Medicine, Infectology Orientation, of the Faculty of Medicine, University of Buenos Aires. Dr. Cahn has been involved in international HIV/AIDS conferences and working groups since 1989, including the 1st Conference on Pathogenesis and Treatment of IAS in Argentina and the XVII International AIDS Conference in Mexico, which he chaired. Likewise, on repeated occasions, he has acted as an advisor to the Pan American Health Organization (PAHO), the World Health Organization (WHO) and UNAIDS. He is an Illustrious Citizen of the City of Buenos Aires and received the honorable mention “Senator Domingo F. Sarmiento” by the Senate of the Nation (2014).

Dr. Valeria Cantos completed her medical degree in Quito, Ecuador. She completed her residency in Internal Medicine and a subspecialty in Infectious Diseases at Emory University in Atlanta. She is an Associate Professor in the Division of Infectious Diseases at Emory, an attending physician at Grady Memorial Hospital, and the Ponce de León Center at Grady, which specializes in the care of people living with HIV.

Dr. Cantos’ research focuses on HIV prevention in Latino communities living in the United States. She is also a co-investigator at the Emory/Ponce de León Clinical Research Site, where she is involved in clinical trials related to pre-exposure prophylaxis (PrEP) and sexual health.

Claudia P. Cortés MD.

Dr. Cortes is a specialist in infectious diseases and internal medicine. Since 2005, have been dedicated to HIV/AIDS in both patient care and research. She has a position as Associate Professor at the University of Chile with academic activities involving undergraduate, postgraduate, and doctoral students.

Dr. Cortes has worked at Fundación Arriarán, Chile’s first and largest HIV treatment center, for more than 16 years, where she has clinical duties in the care of PLWH. She has served on the Chilean Infectious Diseases Society’s HIV advisory group as a member and chair (SOCHINF). She is the former vice president of SOCHINF.

She works as an acting consultant for the Chilean Ministry of Health, where she has contributed to the establishment and revision of national clinical guidelines for HIV/AIDS care, as well as participation in several committees focused on HIV prevention, testing, and treatment initiatives. She is currently a member of the Ministry of Health’s COVID-19 national guidelines advisory council.

Associate Researcher at the Center for Technological, Biomedical, and Environmental Research (CITBM), part of the PERU Clinical Trials Unit, affiliated with the National University of San Marcos. His specialty is Infectious Diseases, with a focus on HIV vaccines, biomedical HIV prevention, pre-exposure prophylaxis (PrEP), and sexually transmitted infections (STIs). His research encompasses clinical trials on HIV vaccines, PrEP implementation, and innovative strategies for STI prevention.

Dr. Gallardo-Cartagena is a Registered Investigator in multiple studies within the HIV Vaccine Trials Network (HVTN), HIV Prevention Trials Network (HPTN), and Advancing Clinical Therapeutics Globally (ACTG). Additionally, he serves as Co-/Vice-Chair of various clinical trials and leads research on PrEP adherence, STI screening, and post-exposure prophylaxis with doxycycline (Doxy-PEP).

Senior Researcher at the HIV Clinic of the Infectious Diseases Department at the Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán  (INCMNSZ) since 2008. She is member of the Mexican National System of Researchers since 2010, currently level II. Assistant Professor of the HIV/AIDS Program at the Universidad Nacional Autónoma de México (UNAM). CRS Coordinator of the Mexican site from the AIDS Clinical Trial Groups (ACTG) Network since December 2020. Sub-investigator of the MOSAICO study at the Mexico City site.

Member of the Mexican Association of Infectious Diseases and Clinical Microbiology (AMIMC) since 2007. Chair of the AMIMC HIV Committee from 2015-2017. Member of the International AIDS Society since 2007. Local Chair of the International AIDS Society (IAS) Scientific Conference held in Mexico City in 2019. Appointed as part of the scientific committee to be leader of the “clinical track” of the World AIDS Conference of the IAS in Montreal in 2022.